Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Scollon S, Anglin AK, Thomas M, Turner JT, Wolfe Schneider K.

J Genet Couns. 2017 Jun;26(3):387-434. doi: 10.1007/s10897-017-0077-8. Epub 2017 Mar 29. Review.

PMID:
28357779
2.

The effect of the toxic dinoflagellate Alexandrium fundyense on the fitness of the calanoid copepod Calanus finmarchicus.

Roncalli V, Turner JT, Kulis D, Anderson DM, Lenz PH.

Harmful Algae. 2016 Jan;51:56-66. Epub 2015 Dec 14.

3.

Zooplankton Community Grazing Impact on a Toxic Bloom of Alexandrium fundyense in the Nauset Marsh System, Cape Cod, Massachusetts, USA.

Petitpas CM, Turner JT, Keafer BA, McGillicuddy DJ Jr, Anderson DM.

Harmful Algae. 2015 Jul;47:42-55. Epub 2015 Jun 12.

4.

Using new tools to identify eggs of Engraulis anchoita (Clupeiformes, Engraulidae).

Favero JM, Katsuragawa M, Zani-Teixeira ML, Turner JT.

J Fish Biol. 2015 Feb;86(2):822-826. doi: 10.1111/jfb.12594. Epub 2014 Dec 26.

PMID:
25545049
5.
7.

Carbon nanotube composites as multifunctional substrates for in situ actuation of differentiation of human neural stem cells.

Landers J, Turner JT, Heden G, Carlson AL, Bennett NK, Moghe PV, Neimark AV.

Adv Healthc Mater. 2014 Nov;3(11):1745-52. doi: 10.1002/adhm.201400042. Epub 2014 Apr 22. No abstract available.

8.

The effects of four different stroke patterns on manual wheelchair propulsion and upper limb muscle strain.

Kwarciak AM, Turner JT, Guo L, Richter WM.

Disabil Rehabil Assist Technol. 2012 Nov;7(6):459-63. doi: 10.3109/17483107.2011.650781. Epub 2012 Feb 1.

PMID:
22295946
9.

Effects of single-variable biofeedback on wheelchair handrim biomechanics.

Richter WM, Kwarciak AM, Guo L, Turner JT.

Arch Phys Med Rehabil. 2011 Apr;92(4):572-7. doi: 10.1016/j.apmr.2010.11.001.

PMID:
21440701
10.

Comparing handrim biomechanics for treadmill and overground wheelchair propulsion.

Kwarciak AM, Turner JT, Guo L, Richter WM.

Spinal Cord. 2011 Mar;49(3):457-62. doi: 10.1038/sc.2010.149. Epub 2010 Nov 2.

11.

Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations.

Johnston JJ, Sapp JC, Turner JT, Amor D, Aftimos S, Aleck KA, Bocian M, Bodurtha JN, Cox GF, Curry CJ, Day R, Donnai D, Field M, Fujiwara I, Gabbett M, Gal M, Graham JM, Hedera P, Hennekam RC, Hersh JH, Hopkin RJ, Kayserili H, Kidd AM, Kimonis V, Lin AE, Lynch SA, Maisenbacher M, Mansour S, McGaughran J, Mehta L, Murphy H, Raygada M, Robin NH, Rope AF, Rosenbaum KN, Schaefer GB, Shealy A, Smith W, Soller M, Sommer A, Stalker HJ, Steiner B, Stephan MJ, Tilstra D, Tomkins S, Trapane P, Tsai AC, Van Allen MI, Vasudevan PC, Zabel B, Zunich J, Black GC, Biesecker LG.

Hum Mutat. 2010 Oct;31(10):1142-54. doi: 10.1002/humu.21328.

12.

Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients.

Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Lowry RB, Biesecker LG.

Am J Med Genet A. 2007 Dec 15;143A(24):2944-58.

PMID:
17963221
13.

Rare and fatal complication of Gianturco tracheobronchial stent.

Asopa S, Moorjani N, Saad RA, Turner JT, Amer KM.

Ann Thorac Surg. 2007 Nov;84(5):1758-60.

PMID:
17954110
14.

Zoom-in comparative genomic hybridisation arrays for the characterisation of variable breakpoint contiguous gene syndromes.

Johnston JJ, Walker RL, Davis S, Facio F, Turner JT, Bick DP, Daentl DL, Ellison JW, Meltzer PS, Biesecker LG.

J Med Genet. 2007 Jan;44(1):e59. Epub 2006 Nov 10.

15.

Evolution of skin lesions in Proteus syndrome.

Twede JV, Turner JT, Biesecker LG, Darling TN.

J Am Acad Dermatol. 2005 May;52(5):834-8.

PMID:
15858474
16.

Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations.

Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, Abbott MH, Aughton DJ, Aylsworth AS, Bamshad MJ, Booth C, Curry CJ, David A, Dinulos MB, Flannery DB, Fox MA, Graham JM, Grange DK, Guttmacher AE, Hannibal MC, Henn W, Hennekam RC, Holmes LB, Hoyme HE, Leppig KA, Lin AE, Macleod P, Manchester DK, Marcelis C, Mazzanti L, McCann E, McDonald MT, Mendelsohn NJ, Moeschler JB, Moghaddam B, Neri G, Newbury-Ecob R, Pagon RA, Phillips JA, Sadler LS, Stoler JM, Tilstra D, Walsh Vockley CM, Zackai EH, Zadeh TM, Brueton L, Black GC, Biesecker LG.

Am J Hum Genet. 2005 Apr;76(4):609-22. Epub 2005 Feb 28.

17.

Hypothalamic hamartomas and seizures: distinct natural history of isolated and Pallister-Hall syndrome cases.

Boudreau EA, Liow K, Frattali CM, Wiggs E, Turner JT, Feuillan P, Sato S, Patsalides A, Patronas N, Biesecker LG, Theodore WH.

Epilepsia. 2005 Jan;46(1):42-7.

18.

Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases.

Turner JT, Cohen MM Jr, Biesecker LG.

Am J Med Genet A. 2004 Oct 1;130A(2):111-22. Review.

PMID:
15372514
19.

Cutaneous manifestations of proteus syndrome: correlations with general clinical severity.

Nguyen D, Turner JT, Olsen C, Biesecker LG, Darling TN.

Arch Dermatol. 2004 Aug;140(8):947-53.

PMID:
15313810
20.

Gonadal mosaicism in severe Pallister-Hall syndrome.

Ng D, Johnston JJ, Turner JT, Boudreau EA, Wiggs EA, Theodore WH, Biesecker LG.

Am J Med Genet A. 2004 Jan 30;124A(3):296-302. Erratum in: Am J Med Genet A. 2005 Jul 15;136(2):225.

PMID:
14708104
21.

Proteus syndrome: misdiagnosis with PTEN mutations.

Cohen MM Jr, Turner JT, Biesecker LG.

Am J Med Genet A. 2003 Nov 1;122A(4):323-4. No abstract available.

PMID:
14518070
22.

Functional P2Y2 nucleotide receptors mediate uridine 5'-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries.

Seye CI, Kong Q, Erb L, Garrad RC, Krugh B, Wang M, Turner JT, Sturek M, González FA, Weisman GA.

Circulation. 2002 Nov 19;106(21):2720-6.

PMID:
12438299
23.

Thromboembolism in patients on thalidomide for myeloma.

Bowcock SJ, Rassam SM, Ward SM, Turner JT, Laffan M.

Hematology. 2002 Feb;7(1):51-3.

PMID:
12171777
24.

Measuring quality of care with an inpatient elderly population. The geriatric resource nurse model.

Turner JT, Lee V, Fletcher K, Hudson K, Barton D.

J Gerontol Nurs. 2001 Mar;27(3):8-18.

PMID:
11915260
25.

PTEN mutations and proteus syndrome.

Biesecker LG, Rosenberg MJ, Vacha S, Turner JT, Cohen MM.

Lancet. 2001 Dec 15;358(9298):2079-80. No abstract available.

PMID:
11755638
26.

An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction.

Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC, Griffin K, Neal C, Krugh B, Santiago-Pérez LI, González FA, Gresham HD, Turner JT, Weisman GA.

J Cell Biol. 2001 Apr 30;153(3):491-501.

27.

Reversible regulation of P2Y(2) nucleotide receptor expression in the duct-ligated rat submandibular gland.

Ahn JS, Camden JM, Schrader AM, Redman RS, Turner JT.

Am J Physiol Cell Physiol. 2000 Aug;279(2):C286-94.

28.

Extracellular UTP stimulates electrogenic bicarbonate secretion across CFTR knockout gallbladder epithelium.

Clarke LL, Harline MC, Gawenis LR, Walker NM, Turner JT, Weisman GA.

Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G132-8.

29.

Furosemide stimulates K transport in HCD57 erythroid cells.

Kim HD, Turner JT, Burnett JE, Joo NS, Han BH, Lim RW, Bowen JW, Kirk RG, Lee P.

J Membr Biol. 2000 Jun 1;175(3):235-44.

PMID:
10833533
30.

Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor.

Otero M, Garrad RC, Velázquez B, Hernández-Pérez MG, Camden JM, Erb L, Clarke LL, Turner JT, Weisman GA, González FA.

Mol Cell Biochem. 2000 Feb;205(1-2):115-23.

PMID:
10821429
31.
32.

Salivary gland P2 nucleotide receptors.

Turner JT, Landon LA, Gibbons SJ, Talamo BR.

Crit Rev Oral Biol Med. 1999;10(2):210-24. Review.

PMID:
10759423
33.

Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors.

Abbott KL, Robida AM, Davis ME, Pavlath GK, Camden JM, Turner JT, Murphy TJ.

J Mol Cell Cardiol. 2000 Mar;32(3):391-403.

PMID:
10731439
34.

Desensitization of P2Y2 receptor-activated transepithelial anion secretion.

Clarke LL, Harline MC, Otero MA, Glover GG, Garrad RC, Krugh B, Walker NM, González FA, Turner JT, Weisman GA.

Am J Physiol. 1999 Apr;276(4):C777-87. doi: 10.1152/ajpcell.1999.276.4.C777.

PMID:
10199807
35.

Salivary gland nucleotide receptors: evidence for functional expression of both P2X and P2Y subtypes.

Turner JT, Weisman GA, Landon LA, Park M, Camden JM.

Eur J Morphol. 1998 Aug;36 Suppl:170-5.

PMID:
9825916
36.

Development and characterization of immortalized rat parotid and submandibular acinar cell lines.

Quissell DO, Turner JT, Redman RS.

Eur J Morphol. 1998 Aug;36 Suppl:50-4.

PMID:
9825893
37.

Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus.

Garrad RC, Otero MA, Erb L, Theiss PM, Clarke LL, Gonzalez FA, Turner JT, Weisman GA.

J Biol Chem. 1998 Nov 6;273(45):29437-44.

38.

A rat parotid gland cell line, Par-C10, exhibits neurotransmitter-regulated transepithelial anion secretion.

Turner JT, Redman RS, Camden JM, Landon LA, Quissell DO.

Am J Physiol. 1998 Aug;275(2):C367-74. doi: 10.1152/ajpcell.1998.275.2.C367.

PMID:
9688590
39.

Development and characterization of SV40 immortalized rat parotid acinar cell lines.

Quissell DO, Barzen KA, Redman RS, Camden JM, Turner JT.

In Vitro Cell Dev Biol Anim. 1998 Jan;34(1):58-67.

PMID:
9542637
40.

Salivary gland nucleotide receptors. Changes in expression and activity related to development and tissue damage.

Turner JT, Park M, Camden JM, Weisman GA.

Ann N Y Acad Sci. 1998 Apr 15;842:70-5.

PMID:
9599295
41.

Upregulation of P2Y2 nucleotide receptors in rat salivary gland cells during short-term culture.

Turner JT, Weisman GA, Camden JM.

Am J Physiol. 1997 Sep;273(3 Pt 1):C1100-7.

PMID:
9316432
42.

Identification and characterization of P2Y2 nucleotide receptors in human retinal pigment epithelial cells.

Sullivan DM, Erb L, Anglade E, Weisman GA, Turner JT, Csaky KG.

J Neurosci Res. 1997 Jul 1;49(1):43-52.

PMID:
9211988
43.

Changes in P2Y1 nucleotide receptor activity during the development of rat salivary glands.

Park MK, Garrad RC, Weisman GA, Turner JT.

Am J Physiol. 1997 Apr;272(4 Pt 1):C1388-93.

PMID:
9142866
44.

Development and characterization of SV40 immortalized rat submandibular acinar cell lines.

Quissell DO, Barzen KA, Gruenert DC, Redman RS, Camden JM, Turner JT.

In Vitro Cell Dev Biol Anim. 1997 Mar;33(3):164-73.

PMID:
9112124
45.

Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes.

Koshiba M, Apasov S, Sverdlov V, Chen P, Erb L, Turner JT, Weisman GA, Sitkovsky MV.

Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):831-6.

46.

Psychiatric codes and billing patterns under Medicare, 1987-1990.

Turner JT, McCue MJ.

Adm Policy Ment Health. 1997 Jan;24(3):243-9. No abstract available.

PMID:
9097880
47.

Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.

Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR.

Br J Pharmacol. 1996 Dec;119(7):1301-3.

48.

PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.

Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR.

Br J Pharmacol. 1996 Jun;118(3):704-10.

49.

Effects of endophyte-infected tall fescue, environmental temperature and prazosin injection on the rat.

Larson BT, Samford MD, Turner JT, Kerley MS, Paterson JA.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 May;114(1):39-44.

PMID:
8689528
50.

Structure and function of P2 purinocepters.

Weisman GA, Turner JT, Fedan JS.

J Pharmacol Exp Ther. 1996 Apr;277(1):1-9. No abstract available.

PMID:
8613904

Supplemental Content

Loading ...
Support Center